pyrimethamine has been researched along with Pneumonia, Pneumocystis in 101 studies
Maloprim: contains above 2 cpds
Pneumonia, Pneumocystis: A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent toxoplasmic encephalitis relapse in patients with the acquired immunodeficiency syndrome (AIDS)." | 9.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "To evaluate combined prophylaxis for Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis, 533 patients with symptomatic human immunodeficiency virus infection and/or CD4 lymphocyte counts of < 200/microL were randomized to receive dapsone/pyrimethamine (200/75 mg once weekly) or aerosolized pentamidine (300 mg every 4 weeks)." | 9.08 | Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. ( Heald, A; Hirschel, B; Iten, A; Lazzarin, A; Oertle, D; Opravil, M; Pechère, M; Praz, G; Rüttimann, S; von Overbeck, J, 1995) |
| "To evaluate the safety and efficacy of a fixed 25mg pyrimethamine--500mg sulfadoxine combination plus 15mg folinic acid given twice weekly for the prevention of relapses of Pneumocystis carinii pneumonia (PCP) and primary episodes of toxoplasmic encephalitis." | 7.71 | Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. ( Albrecht, H; Behnsch, M; Bergmann, F; Grobusch, M; Grünewald, T; Padberg, J; Ruf, B; Schürmann, D; Suttorp, N; Vallée, M; Wünsche, T, 2001) |
| "The efficacy and safety of 25 mg pyrimethamine plus 500 mg sulfadoxine given twice a week in preventing relapses of AIDS-related toxoplasmic encephalitis was evaluated in an open study." | 7.68 | Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. ( Bergmann, F; Gottschalk, HJ; Grünewald, T; Pohle, HD; Ruf, B; Schüler-Maué, W; Schürmann, D; Witt, H, 1993) |
| "The incidence of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) was analyzed in 83 human immunodeficiency virus (HIV)-infected patients who inhaled aerosolized pentamidine (AP) either for primary prophylaxis (group Ia) or secondary prophylaxis (group IIa) of PCP." | 7.68 | Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. ( Gottschalk, J; Grünewald, T; Jautzke, G; Köppen, S; Pohle, HD; Ruf, B, 1992) |
| "We assessed the incidence and determinants of bacteremia, pneumonia, and sinusitis/otitis in HIV-positive people receiving cotrimoxazole (CTX) or dapsone-pyrimethamine (DP) for primary prophylaxis of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) within a randomized clinical trial." | 5.09 | Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial. ( Ammassari, A; Antinori, A; Cingolani, A; De Luca, A; Grillo, R; Murri, R; Pallavicini, F; Pezzotti, P, 2001) |
| "To evaluate the efficacy of twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent toxoplasmic encephalitis relapse in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "To evaluate combined prophylaxis for Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis, 533 patients with symptomatic human immunodeficiency virus infection and/or CD4 lymphocyte counts of < 200/microL were randomized to receive dapsone/pyrimethamine (200/75 mg once weekly) or aerosolized pentamidine (300 mg every 4 weeks)." | 5.08 | Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. ( Heald, A; Hirschel, B; Iten, A; Lazzarin, A; Oertle, D; Opravil, M; Pechère, M; Praz, G; Rüttimann, S; von Overbeck, J, 1995) |
| "In a meta-analysis, we examined the efficacy of aerosolized pentamidine, trimethoprim-sulfamethoxazole, and dapsone or dapsone/pyrimethamine for the prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in patients with HIV infection." | 4.79 | Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. ( Bucher, HC; Griffith, L; Guyatt, GH; Opravil, M, 1997) |
| "The widespread emergence of chloroquine-resistant Plasmodium falciparum led to the formulation of an effective, fixed combination of two antimalarial agents, pyrimethamine and the long-acting sulfonamide sulfadoxine, for prophylaxis and treatment." | 4.77 | Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. ( Hewlett, EL; Pearson, RD, 1987) |
| "To evaluate the safety and efficacy of a fixed 25mg pyrimethamine--500mg sulfadoxine combination plus 15mg folinic acid given twice weekly for the prevention of relapses of Pneumocystis carinii pneumonia (PCP) and primary episodes of toxoplasmic encephalitis." | 3.71 | Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. ( Albrecht, H; Behnsch, M; Bergmann, F; Grobusch, M; Grünewald, T; Padberg, J; Ruf, B; Schürmann, D; Suttorp, N; Vallée, M; Wünsche, T, 2001) |
| "The efficacy and safety of 25 mg pyrimethamine plus 500 mg sulfadoxine given twice a week in preventing relapses of AIDS-related toxoplasmic encephalitis was evaluated in an open study." | 3.68 | Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. ( Bergmann, F; Gottschalk, HJ; Grünewald, T; Pohle, HD; Ruf, B; Schüler-Maué, W; Schürmann, D; Witt, H, 1993) |
| "The incidence of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) was analyzed in 83 human immunodeficiency virus (HIV)-infected patients who inhaled aerosolized pentamidine (AP) either for primary prophylaxis (group Ia) or secondary prophylaxis (group IIa) of PCP." | 3.68 | Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. ( Gottschalk, J; Grünewald, T; Jautzke, G; Köppen, S; Pohle, HD; Ruf, B, 1992) |
| "The combination of pyrimethamine and sulfadoxine (Fansidar) has been reported to cause severe skin reactions including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis." | 3.67 | Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. ( Dinan, WA; Pablos-Mendez, A; Palagiano, A; Raviglione, MC; Sabatini, MT, 1988) |
| " The pharmacokinetics of dapsone and pyrimethamine were examined by using a population pharmacokinetic model." | 2.67 | Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia. ( Amantea, MA; Byrne, A; Davey, RT; Falloon, J; Graziani, A; Lavelle, J; Morgan, A; Ogata-Arakaki, D; Ownby, K; Polis, M, 1994) |
| "Although the incidence of Pneumocystis carinii pneumonia (PCP) among adults infected with human immunodeficiency virus (HIV) has declined, no decline in PCP incidence has been observed among HIV-infected children, and PCP remains the most common serious opportunistic infection among both adults and children in the United States." | 2.39 | Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. ( Feinberg, J; Hughes, WT; Navin, TR; Simonds, RJ, 1995) |
| "Although Pneumocystis carinii pneumonia (PCP) can occur in any patient with severe impairment of immunity, there has been a sharp rise in incidence with the spread of human immunodeficiency virus through the USA and Western Europe, where nearly 80% of patients with HIV infection have at least one episode of PCP during their lifetime (Murray et al, 1984)." | 2.38 | Prophylaxis and treatment of Pneumocystis carinii pneumonia. ( Bateman, NT; O'Doherty, MJ, 1991) |
| " Dosage must be adjusted to the results of blood counts." | 2.38 | [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. ( Leport, C; Niyongabo, T; Vildé, JL, 1991) |
| "Treatment with trimethoprim-sulfamethoxazole (TMP) should be instituted as early as possible: a serum level of TMP between 5 and 10 micrograms/ml should be attained." | 2.37 | [Pneumocystis carinii infections]. ( Mojon, M, 1985) |
| "To analyse the incidence of Pneumocystis carinii pneumonia after the withdrawal of prophylaxis, in patients with AIDS who were receiving HAART (highly active antiretroviral treatment)." | 1.30 | [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. ( de Górgolas Hernández, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E, 1999) |
| "Pneumocystis carinii pneumonia has been the most common life-threatening opportunistic infection in patients with acquired immunodeficiency syndrome." | 1.29 | Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia. ( Glatt, AE, 1994) |
| "Extrapulmonary pneumocystosis is a feature of severe immunosuppression which earlier reports have suggested is limited to patients receiving either no prophylaxis or aerosolised pentamidine." | 1.29 | Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis. ( Carlin, EM; Coker, RJ; Goldin, RD; Harris, JR, 1993) |
| "Patients with cerebral toxoplasmosis have a low risk for subsequently developing P." | 1.28 | Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. ( Chave, JP; Flepp, M; Gabriel, V; Heald, A; Hirschel, B; Malinverni, R; Renold, C; Rüttimann, S; Sugar, A, 1991) |
| "In 33 consecutive AIDS patients with a first episode of Pneumocystis carinii pneumonia (PCP) we evaluated treatment, outcome, recurrence rate and pyrimethamine as chemoprophylaxis in a 1-year follow-up." | 1.28 | Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. ( Bergdahl, S; Julander, I; Lidman, C; Lundbergh, P; Ortqvist, A, 1989) |
| "Pneumocystis carinii pneumonia is an important infection in patients infected with the human immunodeficiency virus." | 1.28 | Experience with pneumocystis carinii pneumonia in patients with AIDS. ( Davis, R; Ellis-Pegler, RB; Ingram, RJ, 1989) |
| "Infantile pneumocystosis leading to IPCP can be completely prevented by proper feeding and care of the patient or prophylactic drug therapy with sulfadoxine-pyrimethamine." | 1.26 | Therapy and prophylaxis of Pneumocystis carinii pneumonia. ( Bandarizadeh, B; Dutz, W; Fakouhi, T; Jennings-Khodadad, E; Kohout, E; Post, C, 1976) |
| "There are two types of Pneumocystis carinii pneumonia." | 1.26 | [Current aspects of differentiation and treatment of pneumocystis carinii pneumonia (author's transl)]. ( Ivády, G, 1976) |
| "Pneumocystis carinii pneumonia was suspected in 52 patients who underwent lung biopsy for diagnosis of diffuse pulmonary infiltrates." | 1.25 | Pneumocystis carinii pneumonia. Diagnosis by lung biopsy. ( Armstrong, D; Martini, N; Rosen, PP, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 49 (48.51) | 18.7374 |
| 1990's | 47 (46.53) | 18.2507 |
| 2000's | 5 (4.95) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queener, SF | 2 |
| Piper, JR | 1 |
| Johnson, CA | 1 |
| Krauth, CA | 1 |
| Carter, RL | 1 |
| Hosmer, CA | 1 |
| Borotz, SE | 1 |
| Pfefferkorn, ER | 1 |
| Baran, DA | 1 |
| Alwarshetty, MM | 1 |
| Alvi, S | 1 |
| Arroyo, LH | 1 |
| Lubitz, S | 1 |
| Pinney, S | 1 |
| Gass, AL | 1 |
| Zucker, MJ | 1 |
| Reusser, P | 1 |
| Gottlieb, MS | 1 |
| Knight, S | 1 |
| Mitsuyasu, R | 1 |
| Weisman, J | 1 |
| Roth, M | 1 |
| Young, LS | 1 |
| von Sonnenburg, F | 1 |
| Prüfer, L | 1 |
| Hughes, WT | 4 |
| Podzamczer, D | 4 |
| Miró, JM | 3 |
| Bolao, F | 2 |
| Gatell, JM | 4 |
| Cosín, J | 1 |
| Sirera, G | 2 |
| Domingo, P | 1 |
| Laguna, F | 1 |
| Santamaría, J | 1 |
| Verdejo, J | 1 |
| Salazar, A | 1 |
| Jiménez, J | 2 |
| Consiglio, E | 1 |
| Santín, M | 3 |
| Casanova, A | 2 |
| Rufí, G | 1 |
| Gudiol, F | 2 |
| Opravil, M | 5 |
| Pechère, M | 2 |
| Lazzarin, A | 2 |
| Heald, A | 3 |
| Rüttimann, S | 3 |
| Iten, A | 2 |
| Furrer, H | 1 |
| Oertle, D | 2 |
| Praz, G | 2 |
| Vuitton, DA | 1 |
| Hirschel, B | 2 |
| von Overbeck, J | 1 |
| Bessesen, MT | 1 |
| Miller, LA | 1 |
| Cohn, DL | 1 |
| Bartlett, S | 1 |
| Ellison, RT | 1 |
| Jurado, R | 1 |
| Garcia-Herola, A | 1 |
| Garcia-Lazaro, M | 1 |
| Kindelan, JM | 1 |
| Villanueva, JL | 1 |
| Torre-Cisneros, J | 2 |
| Falloon, J | 1 |
| Lavelle, J | 1 |
| Ogata-Arakaki, D | 1 |
| Byrne, A | 1 |
| Graziani, A | 1 |
| Morgan, A | 1 |
| Amantea, MA | 1 |
| Ownby, K | 1 |
| Polis, M | 1 |
| Davey, RT | 1 |
| Tocchetti, A | 1 |
| Tambini, R | 1 |
| Allegro, A | 1 |
| Longoni, E | 1 |
| Rinaldi, E | 1 |
| Joos, B | 1 |
| Lüthy, R | 2 |
| Jacobson, MA | 1 |
| Besch, CL | 1 |
| Child, C | 1 |
| Hafner, R | 1 |
| Matts, JP | 1 |
| Muth, K | 1 |
| Wentworth, DN | 1 |
| Neaton, JD | 1 |
| Abrams, D | 1 |
| Rimland, D | 1 |
| Glatt, AE | 1 |
| Ruf, B | 4 |
| Schürmann, D | 3 |
| Bergmann, F | 3 |
| Schüler-Maué, W | 1 |
| Grünewald, T | 4 |
| Gottschalk, HJ | 1 |
| Witt, H | 1 |
| Pohle, HD | 2 |
| Mallolas, J | 3 |
| Zamora, L | 3 |
| Vernet, E | 1 |
| Valls, ME | 1 |
| Soriano, E | 2 |
| SanMiguel, JG | 1 |
| Martos, A | 1 |
| Ferrer, I | 1 |
| Girard, PM | 2 |
| Landman, R | 1 |
| Gaudebout, C | 2 |
| Olivares, R | 1 |
| Saimot, AG | 1 |
| Jelazko, P | 1 |
| Certain, A | 1 |
| Boué, F | 1 |
| Bouvet, E | 1 |
| Gudiol, GR | 1 |
| Carlin, EM | 1 |
| Coker, RJ | 2 |
| Goldin, RD | 1 |
| Harris, JR | 2 |
| Keusch, G | 1 |
| Simonds, RJ | 1 |
| Feinberg, J | 1 |
| Navin, TR | 2 |
| Antinori, A | 4 |
| Murri, R | 4 |
| Ammassari, A | 2 |
| De Luca, A | 4 |
| Linzalone, A | 1 |
| Cingolani, A | 2 |
| Damiano, F | 1 |
| Maiuro, G | 1 |
| Vecchiet, J | 1 |
| Scoppettuolo, G | 1 |
| Tamburrini, E | 2 |
| Mencarini, P | 1 |
| Visconti, E | 1 |
| Zolfo, M | 1 |
| Siracusano, A | 1 |
| Ortona, E | 1 |
| Bucher, HC | 1 |
| Griffith, L | 1 |
| Guyatt, GH | 1 |
| Teira, R | 1 |
| Virosta, M | 1 |
| Muñoz, J | 1 |
| Zubero, Z | 1 |
| Santamaría, JM | 1 |
| Fishman, JA | 1 |
| Payen, MC | 1 |
| De Wit, S | 1 |
| Sommereijns, B | 1 |
| Clumeck, N | 1 |
| García Vázquez, E | 1 |
| de Górgolas Hernández, M | 1 |
| García Delgado, R | 1 |
| Fernández Guerrero, ML | 1 |
| Arendt, G | 1 |
| von Giesen, HJ | 1 |
| Hefter, H | 1 |
| Neuen-Jacob, E | 1 |
| Roick, H | 1 |
| Jablonowski, H | 1 |
| De la Mata, M | 1 |
| Pozo, JC | 1 |
| Serrano, P | 1 |
| Briceño, J | 1 |
| Solórzano, G | 1 |
| Miño, G | 1 |
| Pera, C | 1 |
| Sánchez-Guijo, P | 1 |
| Albrecht, H | 2 |
| Padberg, J | 2 |
| Behnsch, M | 1 |
| Grobusch, M | 2 |
| Vallée, M | 2 |
| Wünsche, T | 2 |
| Suttorp, N | 2 |
| Asencio Marchante, R | 1 |
| Lissen Otero, E | 1 |
| Dorrell, L | 1 |
| McCallum, AK | 1 |
| Snow, MH | 1 |
| Ong, EL | 1 |
| Cheng, B | 1 |
| Walker, MJ | 1 |
| Pezzotti, P | 1 |
| Pallavicini, F | 1 |
| Grillo, R | 1 |
| Schürmann, M | 1 |
| Danilevicius, Z | 1 |
| Ryning, FW | 1 |
| Mills, J | 1 |
| Hallett, JJ | 1 |
| Fickenscher, LG | 1 |
| Ablin, AR | 1 |
| Dutz, W | 3 |
| Post, C | 2 |
| Jennings-Khodadad, E | 1 |
| Fakouhi, T | 2 |
| Kohout, E | 1 |
| Bandarizadeh, B | 2 |
| Rosen, PP | 1 |
| Martini, N | 1 |
| Armstrong, D | 1 |
| Sizoo, W | 1 |
| Wolvius, GG | 1 |
| Ivády, G | 1 |
| Young, RC | 1 |
| DeVita, VT | 2 |
| Iváldy, G | 1 |
| Páldy, L | 1 |
| Whisnant, JK | 1 |
| Buckley, RH | 1 |
| Helmer, RE | 1 |
| Ortona, L | 1 |
| Köppen, S | 1 |
| Jautzke, G | 1 |
| Gottschalk, J | 1 |
| Nieman, R | 1 |
| McBride, M | 1 |
| Mitchell, DM | 1 |
| Weber, JN | 1 |
| Hardy, WD | 2 |
| O'Doherty, MJ | 1 |
| Bateman, NT | 1 |
| Niyongabo, T | 1 |
| Leport, C | 1 |
| Vildé, JL | 1 |
| Vinogradov, NA | 1 |
| Clotet, B | 1 |
| Romeu, J | 1 |
| Gimeno, JM | 1 |
| Jou, A | 1 |
| Condom, MJ | 1 |
| Tor, J | 1 |
| Foz, M | 1 |
| Soma, K | 1 |
| Flepp, M | 1 |
| Chave, JP | 1 |
| Malinverni, R | 1 |
| Gabriel, V | 1 |
| Renold, C | 1 |
| Sugar, A | 1 |
| Takada, S | 1 |
| Lepretre, A | 1 |
| Detruchis, P | 1 |
| Matheron, S | 1 |
| Coulaud, JP | 1 |
| Lidman, C | 1 |
| Ortqvist, A | 1 |
| Lundbergh, P | 1 |
| Julander, I | 1 |
| Bergdahl, S | 1 |
| Gilman, TM | 1 |
| Boylen, CT | 1 |
| Sattler, FR | 1 |
| Ingram, RJ | 1 |
| Davis, R | 1 |
| Ellis-Pegler, RB | 1 |
| Miller, KD | 1 |
| Satriale, RF | 1 |
| Lobel, HO | 1 |
| Kovacs, JA | 1 |
| Masur, H | 1 |
| Frissen, PH | 1 |
| Stronkhorst, A | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| Danner, SA | 1 |
| Walzer, PD | 1 |
| Kim, CK | 1 |
| Foy, JM | 1 |
| Linke, MJ | 1 |
| Cushion, MT | 1 |
| Raviglione, MC | 1 |
| Dinan, WA | 1 |
| Pablos-Mendez, A | 1 |
| Palagiano, A | 1 |
| Sabatini, MT | 1 |
| Fischl, MA | 1 |
| Dickinson, GM | 1 |
| Bath, PM | 1 |
| Lillicrap, DA | 1 |
| Winter, M | 1 |
| Pearson, RD | 1 |
| Hewlett, EL | 1 |
| Szabados, A | 1 |
| Schierz, G | 1 |
| Deinhardt, F | 1 |
| Mojon, M | 1 |
| Catterall, JR | 1 |
| Potasman, I | 1 |
| Remington, JS | 2 |
| Panov, A | 1 |
| Kim, HK | 1 |
| Price, RA | 1 |
| Miller, C | 1 |
| Weiss, EB | 1 |
| Katz, S | 1 |
| Tyras, DH | 1 |
| Campbell, W | 1 |
| Corley, C | 1 |
| Hatcher, CR | 1 |
| Robbins, JB | 1 |
| Boda, D | 1 |
| Anderson, SE | 1 |
| Chobot-Maciejewska, H | 1 |
| Kosicka, M | 1 |
| Januszkiewicz, A | 1 |
| Kohout, EE | 1 |
| Frenkel, JK | 1 |
| Good, JT | 1 |
| Shultz, JA | 1 |
| Kordyasz, E | 1 |
| Ratajczak-Majewska, C | 1 |
| Szmigiel, C | 1 |
| Stopyrowa, J | 1 |
| Baniowski, A | 1 |
| Kirby, HB | 1 |
| Kenamore, B | 1 |
| Guckian, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection[NCT00000666] | 600 participants | Interventional | Completed | ||||
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)[NCT04844099] | Phase 3 | 723 participants (Actual) | Interventional | 2021-04-09 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for pyrimethamine and Pneumonia, Pneumocystis
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infectio | 1995 |
[Progress in immunodiagnosis and chemotherapy of protozoan infections].
Topics: Amebiasis; Animals; Antibodies; Babesiosis; Chloroquine; Drug Resistance, Microbial; Giardiasis; Hum | 1983 |
Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; | 1995 |
Recent advances in the prevention of pneumocystis carinii pneumonia.
Topics: Aerosols; Child; Dapsone; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Trimethoprim, | 1996 |
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal | 1997 |
Prevention of infection due to Pneumocystis carinii.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Fungal Vaccine | 1998 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Prophylaxis and treatment of Pneumocystis carinii pneumonia.
Topics: Antimalarials; CD4-Positive T-Lymphocytes; Clinical Protocols; Dapsone; Drug Combinations; HIV Infec | 1991 |
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Hum | 1991 |
[Diagnosis and treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Diagnosis, Differential; Humans; Pneumonia, Pneumoc | 1991 |
Prophylaxis of AIDS-related opportunistic infections (OIs).
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combin | 1989 |
Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Therapy, Combination; Humans; Pneumonia, Pneumocys | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, | 1988 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneum | 1988 |
Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Topics: Acquired Immunodeficiency Syndrome; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria | 1987 |
[Pneumocystis carinii pneumonia].
Topics: Adult; Animals; Antibodies; Antimalarials; Child; Drug Combinations; Drug Therapy, Combination; Huma | 1985 |
[Pneumocystis carinii infections].
Topics: Animals; Child; Drug Combinations; France; History, 20th Century; Humans; Pentamidine; Pneumonia, Pn | 1985 |
Pneumocystis carinii pneumonia.
Topics: Adolescent; Adult; Apicomplexa; Child; Child, Preschool; Female; Humans; Immunoglobulins; Immunologi | 1970 |
24 trials available for pyrimethamine and Pneumonia, Pneumocystis
| Article | Year |
|---|---|
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Drug Administration Schedule; Drug Therapy, Comb | 1995 |
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Dapsone; Drug Administration Schedule; Drug Ther | 1995 |
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Topics: Adult; CD4 Lymphocyte Count; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Huma | 1995 |
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Animals; Dapsone; Drug Adm | 1995 |
Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Administration, Inhalation; Adolescent; Adult; AIDS-Related Opportunistic Infections; Drug Therapy, | 1995 |
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Biological Availability; Chromatography, High Pressure | 1994 |
Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Female; Follow-Up | 1994 |
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Double-Blind Method; Female; HIV Infections; Humans; M | 1994 |
Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Drug Therapy, Co | 1993 |
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Topics: Adult; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Dapsone; Drug Combinations; Ence | 1993 |
Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Administration Schedule; Drug Therapy, C | 1993 |
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infe | 1995 |
A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infecti | 1997 |
Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Drug Combinations; Female; Humans; Liver Transplantation; Male; | 1999 |
Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial.
Topics: Adult; Animals; Anti-Infective Agents; Bacterial Infections; Dapsone; Encephalitis; Female; HIV Infe | 2001 |
Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Antiretroviral T | 2002 |
Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine.
Topics: Administration, Oral; Adult; Aged; Amidines; Child; Drug Therapy, Combination; Female; Humans; Injec | 1976 |
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.
Topics: Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pneumonia, Pneumocystis; Pyrimethamine; | 1992 |
Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Topics: Adult; CD4-Positive T-Lymphocytes; Dapsone; Drug Administration Schedule; Female; Humans; Leukocyte | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Follow-Up Studies; Humans; Pentamidine; Pneumonia, Pneu | 1991 |
Pneumocystis carinii pneumonia in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bronchoscopy; Clinical Trials as Topic; Dapsone; Drug C | 1985 |
[Results of treatment of pneumocystic pneumonia with pentamidin isethionate and daraprim].
Topics: Amidines; Clinical Trials as Topic; Humans; Infant; Pneumonia, Pneumocystis; Pyrimethamine | 1968 |
Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine+pyrimethamine combination.
Topics: Age Factors; Autopsy; Biopsy; Bone Marrow; Complement Fixation Tests; Female; Folic Acid; Humans; In | 1971 |
60 other studies available for pyrimethamine and Pneumonia, Pneumocystis
| Article | Year |
|---|---|
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
Topics: Animals; Anti-Infective Agents; Folic Acid Antagonists; Opportunistic Infections; Pneumocystis; Pneu | 1996 |
Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers.
Topics: Adult; Anti-Infective Agents; Antiprotozoal Agents; Female; Follow-Up Studies; Graft Rejection; Hear | 2006 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Middle Aged; | 1980 |
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamin | 1984 |
Pneumocystis carinii pneumonitis.
Topics: Animals; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadiazin | 1981 |
Pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Female; Humans; Male; Middle Aged; Pne | 1994 |
Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Adult; Aged; Dapsone; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Phenotyp | 1994 |
Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clindamycin; Dapso | 1994 |
Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Administration Schedule; D | 1993 |
Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Humans; Liver Dise | 1993 |
Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Com | 1993 |
Pyrimethamine inhibits renal secretion of creatinine.
Topics: Adult; Creatinine; Dapsone; Drug Administration Schedule; Drug Interactions; Female; Humans; Kidney; | 1993 |
Prophylaxis of pneumocystis pneumonia and toxoplasmosis.
Topics: Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Humans; Pneumonia, Pneumocystis; Pyrimeth | 1996 |
Imbalance between Pneumocystis carinii cysts and trophozoites in bronchoalveolar lavage fluid from patients with pneumocystosis receiving prophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Bronchoalveo | 1996 |
The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
Topics: Adult; Anti-Infective Agents; Female; Humans; Incidence; Male; Pneumocystis; Pneumonia, Pneumocystis | 1997 |
[Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1999 |
Long-term course and outcome in AIDS patients with cerebral toxoplasmosis.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiprot | 1999 |
Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cohort Studies; Drug Comb | 2001 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal A | 2001 |
Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents | 1995 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
Opportunistic infections studies update.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasi | 1995 |
Editorial: A call to recognize PCP.
Topics: Alkanesulfonates; Amidines; Biopsy; Child; Developing Countries; Drug Therapy, Combination; Humans; | 1975 |
Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host.
Topics: Adolescent; Adult; Animals; Cats; Child; Child, Preschool; Cytomegalovirus Infections; Female; Human | 1979 |
Pneumocystis carinii pneumonia in children.
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadi | 1977 |
Therapy and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Amidines; Aminosalicylic Acid; Animals; Complement Fixation Tests; Drug Therapy, Combination; Humans | 1976 |
Pneumocystis carinii pneumonia. Diagnosis by lung biopsy.
Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; M | 1975 |
[Pneumocystis pneumonia as a complication in cytostatic therapy].
Topics: Adolescent; Antineoplastic Agents; Female; Humans; Male; Neoplasms; Pentamidine; Pneumonia, Pneumocy | 1976 |
[Current aspects of differentiation and treatment of pneumocystis carinii pneumonia (author's transl)].
Topics: Age Factors; Dihydroergotoxine; Humans; Immunologic Deficiency Syndromes; Infant; Pentamidine; Pneum | 1976 |
Treatment of Pneumocystis carinii pneumonia in infancy.
Topics: Dihydroergotoxine; Drug Therapy, Combination; Female; Folic Acid; Humans; Infant; Infant, Newborn; I | 1976 |
Successful pyrimethamine-sulfadiazine therapy of pneumocystis pneumonia in infants with X-linked immunodeficiency with hyper-IgM.
Topics: Dysgammaglobulinemia; Genetic Linkage; Humans; Immunoglobulin M; Infant; Male; Pneumonia, Pneumocyst | 1976 |
Hazard of folinic acid with pyrimethamine and sulfadiazine.
Topics: Amidines; Drug Combinations; Drug Interactions; Humans; Leucovorin; Leukemia; Pentamidine; Pneumonia | 1975 |
Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.
Topics: Adult; Aerosols; Aged; CD4-Positive T-Lymphocytes; Drug Combinations; Encephalitis; Female; HIV Infe | 1992 |
Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Dapsone; Drug Administration Schedule; Drug Ther | 1991 |
[Diagnosis and therapy of parasitic lung diseases].
Topics: Humans; Lung Diseases, Parasitic; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine; | 1991 |
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Clindamycin; Cohort Studies; Drug Therapy, Combinat | 1991 |
[Drugs used against protozoan infections in man].
Topics: Amebiasis; Aminoquinolines; Antiprotozoal Agents; Humans; Malaria; Metronidazole; Pneumonia, Pneumoc | 1990 |
Failure of pyrimethamine-clindamycin combination for prophylaxis of Pneumocystis carinii pneumonia.
Topics: Clindamycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Pneum | 1989 |
Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Evaluation; Drug Therapy, Combination | 1989 |
Experience with pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoscopy; Drug Combinations; Follow-Up Studies; Homos | 1989 |
Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; | 1985 |
Fansidar-associated fatal reaction in an HIV-infected man.
Topics: Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Homosexuality; Humans; Male; Middl | 1988 |
Fansidar and Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; | 1988 |
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Topics: Animals; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Immunosuppression Therapy; Male | 1988 |
Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
Topics: Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Homosexuality; Humans; Male; Middl | 1988 |
Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Male; Middle Aged; Pneumonia, Pneumoc | 1988 |
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamin | 1986 |
Fansidar--a treatment for AIDS-related pneumocystis?
Topics: Acquired Immunodeficiency Syndrome; Antimalarials; Drug Combinations; Humans; Pneumonia, Pneumocysti | 1987 |
[Clinical aspects and treatment of pneumocystic pneumonia].
Topics: gamma-Globulins; Humans; Infant; Pneumonia, Pneumocystis; Pyrimethamine; Quinine; Sulfonamides | 1971 |
Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis.
Topics: Amidines; Animals; Cortisone; Immunization; Male; Pneumonia, Pneumocystis; Pyrimethamine; Rats; Sulf | 1973 |
Editorial: In pursuit of Pneumocystis carinii.
Topics: Biopsy; Bis-Trimethylammonium Compounds; Bronchoscopy; Diagnosis, Differential; Humans; Mycobacteriu | 1973 |
Pneumocystis carinii pneumonia.
Topics: Adult; Alkanesulfonates; Amidines; Biopsy; Biopsy, Needle; Bronchoscopy; Child; Drug Therapy, Combin | 1974 |
The role of early open lung biopsy in the diagnosis and treatment of Pneumocystis carinii pneumonia.
Topics: Adult; Aged; Alkanesulfonates; Amidines; Biopsy; Female; Histiocytes; Humans; Lung; Male; Middle Age | 1974 |
An increasing awareness of pneumocystis carinii pneumonitis.
Topics: Amidines; Antiprotozoal Agents; Humans; Phenols; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadiazin | 1972 |
The importance of insterstitial (plasma cell) pneumonia and its correlation with immunodeficiency.
Topics: Cross Infection; Drug Therapy, Combination; Female; Humans; Immunologic Deficiency Syndromes; Infant | 1972 |
Diagnosis and treatment of pneumocystosis and toxoplasmosis in the immunosuppressed host.
Topics: Anti-Bacterial Agents; Cerebrospinal Fluid; Drug Combinations; Fluorescent Antibody Technique; Hemag | 1973 |
Latent Pneumocystis infection of rats, relapse, and chemotherapy.
Topics: Aminopterin; Animals; Antiprotozoal Agents; Chlorambucil; Chlortetracycline; Cortisone; Cricetinae; | 1966 |
[Successful treatment of infants with pneumonia pneumocystica with daraprim].
Topics: Female; Humans; Infant; Male; Pneumonia, Pneumocystis; Pyrimethamine | 1966 |
[Clinical picture and treatment of pneumocystis carinii pneumonia in infants].
Topics: Anti-Bacterial Agents; Humans; Infant; Infant, Newborn; Oxygen Inhalation Therapy; Pneumonia, Pneumo | 1971 |
Pneumocystis carinii pneumonia treated with pyrimethamine and sulfadiazine.
Topics: Adult; Follow-Up Studies; Humans; Leukemia, Lymphoid; Lupus Erythematosus, Systemic; Lymphoma, Non-H | 1971 |